Cargando…

Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin

Disialoganglioside (GD2) is a subtype of glycolipids that is highly expressed in tumors of neuroectodermal origins, such as neuroblastoma and osteosarcoma. Its limited expression in normal tissues makes GD2 a potential target for precision therapy. Several anti-GD2 monoclonal antibodies are currentl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inagaki, Fuyuki F., Kato, Takuya, Furusawa, Aki, Okada, Ryuhei, Wakiyama, Hiroaki, Furumoto, Hideyuki, Okuyama, Shuhei, Choyke, Peter L., Kobayashi, Hisataka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612122/ https://www.ncbi.nlm.nih.gov/pubmed/36297471 http://dx.doi.org/10.3390/pharmaceutics14102037

Ejemplares similares

CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model
por: Furusawa, Aki, et al.
Publicado: (2022)

Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts
por: Furumoto, Hideyuki, et al.
Publicado: (2022)

Endoscopic near‐infrared photoimmunotherapy in an orthotopic head and neck cancer model
por: Okada, Ryuhei, et al.
Publicado: (2021)

Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy
por: Furumoto, Hideyuki, et al.
Publicado: (2022)

Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors
por: Maruoka, Yasuhiro, et al.
Publicado: (2020)

Intercellular adhesion molecule‐1‐targeted near‐infrared photoimmunotherapy of triple‐negative breast cancer
por: Fukushima, Hiroshi, et al.
Publicado: (2022)

Wound healing after excision of subcutaneous tumors treated with near‐infrared photoimmunotherapy
por: Rosenberg, Adrian, et al.
Publicado: (2020)

Near-Infrared Photoimmunotherapy (NIR-PIT) in Urologic Cancers
por: Fukushima, Hiroshi, et al.
Publicado: (2022)

Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response
por: Kato, Takuya, et al.
Publicado: (2022)

Increased Immunogenicity of a Minimally Immunogenic Tumor after Cancer-Targeting Near Infrared Photoimmunotherapy
por: Wakiyama, Hiroaki, et al.
Publicado: (2020)

Diagnostic imaging in near‐infrared photoimmunotherapy using a commercially available camera for indocyanine green
por: Inagaki, Fuyuki F., et al.
Publicado: (2021)

Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy
por: Wakiyama, Hiroaki, et al.
Publicado: (2022)

Real-Time Fluorescence Imaging Using Indocyanine Green to Assess Therapeutic Effects of Near-Infrared Photoimmunotherapy in Tumor Model Mice
por: Rosenberg, Adrian, et al.
Publicado: (2020)

Near-Infrared Photoimmunotherapy Combined with CTLA4 Checkpoint Blockade in Syngeneic Mouse Cancer Models
por: Maruoka, Yasuhiro, et al.
Publicado: (2020)

Avoiding thermal injury during near-infrared photoimmunotherapy (NIR-PIT): the importance of NIR light power density
por: Okuyama, Shuhei, et al.
Publicado: (2017)

Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials
por: Okada, Ryuhei, et al.
Publicado: (2021)

Near‐infrared photoimmunotherapy through bone
por: Nakamura, Yu A., et al.
Publicado: (2019)

Near infrared photoimmunotherapy of cancer; possible clinical applications
por: Wakiyama, Hiroaki, et al.
Publicado: (2021)

Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy
por: Kato, Takuya, et al.
Publicado: (2021)

NIR-PIT: Will it become a standard cancer treatment?
por: Furusawa, Aki, et al.
Publicado: (2022)

Near infrared photoimmunotherapy for cancers: A translational perspective
por: Maruoka, Yasuhiro, et al.
Publicado: (2021)

Review of RM-1929 Near-Infrared Photoimmunotherapy Clinical Efficacy for Unresectable and/or Recurrent Head and Neck Squamous Cell Carcinoma
por: Miyazaki, Nanami L., et al.
Publicado: (2023)

Effect of Short PEG on Near-Infrared BODIPY-Based Activatable Optical Probes
por: Inagaki, Fuyuki F., et al.
Publicado: (2020)

Near-Infrared Photoimmunotherapy of Cancer
por: Kobayashi, Hisataka, et al.
Publicado: (2019)

Improving the Efficacy of Photoimmunotherapy (PIT) using a Cocktail of Antibody Conjugates in a Multiple Antigen Tumor Model
por: Nakajima, Takahito, et al.
Publicado: (2013)

Near-infrared photoimmunotherapy: a comparison of light dosing schedules
por: Ogata, Fusa, et al.
Publicado: (2017)

Endoscopic near infrared photoimmunotherapy using a fiber optic diffuser for peritoneal dissemination of gastric cancer
por: Nagaya, Tadanobu, et al.
Publicado: (2018)

Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers
por: Cui, Yingshu, et al.
Publicado: (2023)

Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells
por: Wu, Dianna Y., et al.
Publicado: (2003)

Interstitial near-infrared photoimmunotherapy: effective treatment areas and light doses needed for use with fiber optic diffusers
por: Okuyama, Shuhei, et al.
Publicado: (2018)

Fibroblast activation protein targeted near infrared photoimmunotherapy (NIR PIT) overcomes therapeutic resistance in human esophageal cancer
por: Katsube, Ryoichi, et al.
Publicado: (2021)

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
por: Erber, Ramona, et al.
Publicado: (2021)

Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer
por: Harada, Toshiko, et al.
Publicado: (2016)

Photoimmunotherapy of Gastric Cancer Peritoneal Carcinomatosis in a Mouse Model
por: Sato, Kazuhide, et al.
Publicado: (2014)

Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins
Publicado: (1986)

Dynamic changes in the cell membrane on three dimensional low coherent quantitative phase microscopy (3D LC-QPM) after treatment with the near infrared photoimmunotherapy
por: Ogata, Fusa, et al.
Publicado: (2017)

Identification and Tumour-Binding Properties of a Peptide with High Affinity to the Disialoganglioside GD2
por: Müller, Jan, et al.
Publicado: (2016)

Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
por: Nazha, Bassel, et al.
Publicado: (2020)

Targeting disialoganglioside GD2 with chimeric antigen receptor-redirected T cells in lung cancer
por: Reppel, Loïc, et al.
Publicado: (2022)

Near Infrared Photoimmunotherapy in the Treatment of Pleural Disseminated NSCLC: Preclinical Experience
por: Sato, Kazuhide, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_njv5cqvd9ie7pbmjoju9nk3btf